TP53 and prostate cancer: Inhibiting CRLs with MLN4924 stabilizes multiple tumor suppressors (e.g., p53, p21, p27, WEE1, IKBA, CDT1 etc.)triggering growth arrest, DNA damage and apoptosis of prostate cancer, including PC3 cells [37–40].